LGND

Ligand Pharmaceuticals Incorporated (LGND)

About Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Details

Daily high

$115.47

Daily low

$111.00

Price at open

$112.06

52 Week High

$129.90

52 Week Low

$67.53

Market cap

2.2B

Dividend yield

0.00%

Volume

551,595

Avg. volume

137,078

P/E ratio

45.61

Ligand Pharmaceuticals Incorporated News